<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: NKN reduces <z:hpo ids='HP_0002181'>brain edema</z:hpo>, neuronal <z:hpo ids='HP_0011420'>death</z:hpo> and neurological deficits in rats after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, we investigated whether NKN was effective on brain injury in <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> rats </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIAL and METHODS: The middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) model was used to produce experimental <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in adult male Wistar rats </plain></SENT>
<SENT sid="3" pm="."><plain>The activity of SOD and concentration of <z:chebi fb="14" ids="32506">MDA</z:chebi> were determined </plain></SENT>
<SENT sid="4" pm="."><plain>We also examined the efficacy of NKN on neurological deficit scores, expression of <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> receptor and endothelin-1 mRNA in brain of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> rats </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The results show that NKN significantly increased the activity of SOD, decreased the concentration of <z:chebi fb="14" ids="32506">MDA</z:chebi>, decreased neurological deficit scores, inhibited the expression of <z:chebi fb="0" ids="31882">N-methyl-D-aspartate</z:chebi> receptor and endothelin-1 mRNA in brain of focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> rats </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: The results implied NKN could protect brain against injury caused by <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>